Kenvue Inc. is leading the S&P 500 index Monday, with its shares soaring on news of Kimberly-Clark Corp.’s $48.7 billion deal to acquire the Tylenol, Band-Aid and Listerine maker. The stock is up 18%, ...

Despite Berkshire Hathaway being a net seller of stocks for the past three years, Warren Buffett would never sell these two dividend stocks.

Wall Street is looking to keep up a rally that raged throughout October, when investors piled into growth and AI-linked names ...

Berkshire Hathaway (BRK-B, BRK-A) stock is in focus after the company reported earnings. CFRA Research vice president of equity research Cathy Seifert discusses key takeaways from the earnings print, ...

Berkshire Hathaway reported major stock sales last quarter. That includes a further reduction in one of Berkshire's top ...

Supreme Court arguments over tariffs are coming, shutdown milestone approaches, China’s EV sales are slowing, and more news ...

The conglomerate beat analysts' operating profit target, but there were no share buybacks over the third quarter.

Kimberly-Clark agrees to buy Tylenol maker Kenvue in a cash-and-stock deal valued at about $48.7 billion, including debt.

When I started investing, I intuitively knew that I liked dividends. I wasted a lot of time trying other types of investing ...

The major stock indexes were mostly higher in premarket trading on Monday ahead of another busy week of quarterly earnings reports, as well as key private sector employment data.

In other words the stock market is okay with a slightly slower pace of rate cuts if it's accompanied by a steady or improving economy. But Wilson is more cautious on this issue, saying "we are ...

Berkshire Hathaway posted strong Q3 earnings with rising profits, $400B cash, and steady valuation near 1.48x book. Learn why ...